The Polycomb group protein EZH2 directly controls DNA methylation
The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Abstract
The establishment and maintenance of epigenetic gene silencing is fundamental to cell determination and function. The essential epigenetic systems involved in heritable repression of gene activity are the Polycomb group (PcG) proteins and the DNA methylation systems. Here we show that the corresponding silencing pathways are mechanistically linked. We find that the PcG protein EZH2 (Enhancer of Zeste homolog 2) interacts-within the context of the Polycomb repressive complexes 2 and 3 (PRC2/3)-with DNA methyltransferases (DNMTs) and associates with DNMT activity in vivo. Chromatin immunoprecipitations indicate that binding of DNMTs to several EZH2-repressed genes depends on the presence of EZH2. Furthermore, we show by bisulphite genomic sequencing that EZH2 is required for DNA methylation of EZH2-target promoters. Our results suggest that EZH2 serves as a recruitment platform for DNA methyltransferases, thus highlighting a previously unrecognized direct connection between two key epigenetic repression systems.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Neither did Dnmt3a, another chromatin modifying enzyme that is a PRC2 component and is frequently genetically inactivated in myeloid neoplasms (Fig. 5) (31”
From Runx1 regulation of Pu.1 corepressor/coactivator exchange identifies specific molecular targets for leukemia differentiation therapy (2014) · cites this paper as [32]
Citations
Cites
DNA methylation patterns and epigenetic memory
Bird, A. (2002) · Genes & Development · doi:10.1101/gad.947102 · Cited by 7,124
Jaenisch, R., & Bird, A. (2003) · Nature Genetics · doi:10.1038/ng1089 · Cited by 6,325
Role of Histone H3 Lysine 27 Methylation in Polycomb-Group Silencing
Cao, R., Wang, L., Wang, H., Xia, L., Erdjument-Bromage, H., Tempst, P., Jones, R. S., & Zhang, Y. (2002) · Science · doi:10.1126/science.1076997 · Cited by 3,775
Epigenetics in human disease and prospects for epigenetic therapy
Egger, G., Liang, G., Aparicio, A., & Jones, P. A. (2004) · Nature · doi:10.1038/nature02625 · Cited by 3,232
Kuzmichev, A., Nishioka, K., Erdjument-Bromage, H., Tempst, P., & Reinberg, D. (2002) · Genes & Development · doi:10.1101/gad.1035902 · Cited by 1,596
Histone Methyltransferase Activity of a Drosophila Polycomb Group Repressor Complex
Müller, J., Hart, C. M., Francis, N. J., Vargas, M. L., Sengupta, A., Wild, B., Miller, E. L., O'Connor, M. B., Kingston, R. E., & Simon, J. A. (2002) · Cell · doi:10.1016/s0092-8674(02)00976-5 · Cited by 1,562
Czermin, B., Melfi, R., McCabe, D., Seitz, V., Imhof, A., & Pirrotta, V. (2002) · Cell · doi:10.1016/s0092-8674(02)00975-3 · Cited by 1,533
Control of CpNpG DNA methylation by the KRYPTONITE histone H3 methyltransferase
Jackson, J. P., Lindroth, A. M., Cao, X., & Jacobsen, S. E. (2002) · Nature · doi:10.1038/nature731 · Cited by 1,251
Lehnertz, B., Ueda, Y., Derijck, A. A. H. A., Braunschweig, U., Perez-Burgos, L., Kubicek, S., Chen, T., Li, E., Jenuwein, T., & Peters, A. H. F. M. (2003) · Current Biology · doi:10.1016/s0960-9822(03)00432-9 · Cited by 1,245
Role of Histone H3 Lysine 27 Methylation in X Inactivation
Plath, K., Fang, J., Mlynarczyk-Evans, S. K., Cao, R., Worringer, K. A., Wang, H., de la Cruz, C. C., Otte, A. P., Panning, B., & Zhang, Y. (2003) · Science · doi:10.1126/science.1084274 · Cited by 1,195
Cited by
Items 801–900 of 1,004
Momparler, R. L., Idaghdour, Y., Márquez, V. E., & Momparler, L. F. (2012) · Leukemia Research · doi:10.1016/j.leukres.2012.03.001 · Cited by 57
Controlling Transcription with Noncoding RNAs in Mammalian Cells
Turner, A. W., & Morris, K. V. (2010) · BioTechniques · doi:10.2144/000113442 · Cited by 58
Role of EZH2 histone methyltrasferase in melanoma progression and metastasis
Mahmoud, F. A., Shields, B. D., Makhoul, I., Hutchins, L. F., Shalin, S. C., & Tackett, A. J. (2016) · Cancer Biology & Therapy · doi:10.1080/15384047.2016.1167291 · Cited by 57
Tsang, D. P., Wu, W. K. K., Kang, W., Lee, Y., Wu, F., Yu, Z., Xiong, L., Chan, A. W. H., TONG, J. H. M., Yang, W., et al. (2016) · The Journal of Pathology · doi:10.1002/path.4688 · Cited by 57
Recent progress in diatom genomics and epigenomics
Tirichine, L., Rastogi, A., & Bowler, C. (2017) · Current Opinion in Plant Biology · doi:10.1016/j.pbi.2017.02.001 · Cited by 57
Liu, X., Zhang, J., Liu, L., Jiang, Y., Ji, J., Yan, R., Zhu, Z., & Yu, Y. (2018) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2018.05.015 · Cited by 57
Genomic and epigenomic EBF1 alterations modulate TERT expression in gastric cancer
Xing, M., Ooi, W. F., Tan, J. Y., Qamra, A., Lee, P.-H., Li, Z., Xu, C., Padmanabhan, N., Lim, J. Q., Guo, Y. A., et al. (2020) · Journal of Clinical Investigation · doi:10.1172/jci126726 · Cited by 56
Non-canonical functions of EZH2 in cancer
Zimmerman, S. M., Lin, P. N., & Souroullas, G. P. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1233953 · Cited by 56
Senyuk, V. I., Premanand, K., Xu, P., Qian, Z., & Nucifora, G. (2011) · PLoS ONE · doi:10.1371/journal.pone.0020793 · Cited by 56
Superior Efficacy of a Combined Epigenetic Therapy against Human Mantle Cell Lymphoma Cells
Fiskus, W. C., Rao, R., Balusu, R., Ganguly, S., Tao, J., Sotomayor, E. M., Mudunuru, U., Smith, J. E., Hembruff, S. L., Atadja, P. W., et al. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-0873 · Cited by 56
Tiffen, J. C., Wilson, S. P., Gallagher, S. J., Hersey, P., & Filipp, F. V. (2016) · Neoplasia · doi:10.1016/j.neo.2016.01.003 · Cited by 56
Exploring Polypharmacology in Drug Discovery and Repurposing Using the CANDO Platform
Chopra, G., & Samudrala, R. (2016) · Current Pharmaceutical Design · doi:10.2174/1381612822666160325121943 · Cited by 56
Pajares, M. A., & Pérez‐Sala, D. (2017) · Antioxidants and Redox Signaling · doi:10.1089/ars.2017.7237 · Cited by 56
The Evolving Role of Natural Compounds in the Medical Treatment of Uterine Fibroids
Ciebiera, M., Ali, M. K., Prince, L., Jackson-Bey, T., Atabiekov, I., Zgliczyński, S., & Al-Hendy, A. A. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9051479 · Cited by 56
Comprehensive integrative profiling of upper tract urothelial carcinomas
Su, X., Lu, X., Bazai, S. K., Compérat, É., Mouawad, R., Yao, H., Rouprêt, M., Spano, J., Khayat, D., Davidson, I., et al. (2021) · Genome biology · doi:10.1186/s13059-020-02230-w · Cited by 56
PKC isoforms interact with and phosphorylate DNMT1
Lavoie, G., Estève, P., Laulan, N. B., Pradhan, S., & St‐Pierre, Y. (2011) · BMC Biology · doi:10.1186/1741-7007-9-31 · Cited by 56
Oncogenes, Proto-Oncogenes, and Lineage Restriction of Cancer Stem Cells
Brown, G. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22189667 · Cited by 55
Recent advances in understanding the molecular pathogenesis of myelodysplastic syndromes
Kulasekararaj, A. G., Mohamedali, A. M., & Mufti, G. J. (2013) · British Journal of Haematology · doi:10.1111/bjh.12435 · Cited by 55
Liu, D.-C., & Yang, Z. (2011) · Pathology - Research and Practice · doi:10.1016/j.prp.2011.05.010 · Cited by 56
Modulation of Epigenetic Regulators and Cell Fate Decisions by miRNAs
Gruber, A. J., & Zavolan, M. (2013) · Epigenomics · doi:10.2217/epi.13.65 · Cited by 55
Fabiani, E., Leone, G. G. M., Giachelia, M., D’Alò, F., Greco, M., Criscuolo, M., Guidi, F., Rutella, S., Hohaus, S., & Voso, M. T. (2010) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.3109/10428194.2010.528093 · Cited by 55
Wang, H., Liu, W., Black, S., Turner, O., Daniel, J. M., Dean-Colomb, W. M., He, Q. P., Davis, M. B., & Yates, C. C. (2015) · Oncotarget · doi:10.18632/oncotarget.6801 · Cited by 55
Long non-coding RNA PARTICLE bridges histone and DNA methylation
O’Leary, V. B., Hain, S., Maugg, D., Smida, J., Azimzadeh, O., Tapio, S., Ovsepian, S. V., & Atkinson, M. J. (2017) · Scientific Reports · doi:10.1038/s41598-017-01875-1 · Cited by 55
Zheng, Y., Huang, G., Silva, T. C., Yang, Q., Jiang, Y., Koeffler, H. P., Lin, D., & Berman, B. P. (2021) · Nature Communications · doi:10.1038/s41467-021-22720-0 · Cited by 55
Epigenetic Switch at Atp2a2 and Myh7 Gene Promoters in Pressure Overload-Induced Heart Failure
Angrisano, T., Schiattarella, G. G., Keller, S., Pironti, G., Florio, E., Magliulo, F., Bottino, R., Pero, R., Lembo, F., Avvedimento, E. V., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0106024 · Cited by 55
Potassium Channel KCNA1 Modulates Oncogene-Induced Senescence and Transformation
Lallet-Daher, H., Wiel, C., Gitenay, D., Navaratnam, N., Augert, A., Calvé, B. L., Verbeke, S., Carling, D., Aubert, S., Vindrieux, D., et al. (2013) · Cancer Research · doi:10.1158/0008-5472.can-12-3690 · Cited by 57
Self-citationMoskalev, E. A., Luckert, K., Vorobjev, I. A., Mastitsky, S., Gladkikh, A., Stephan, A., Schrenk, M., Kaplanov, K. D., Kalashnikova, O. B., Poetz, O., et al. (2012) · BMC Cancer · doi:10.1186/1471-2407-12-213 · Cited by 55
Maier, V., Feeney, C. M., Taylor, J. E., Creech, A. L., Qiao, J., Szántó, A., Das, P. P., Chevrier, N., Cifuentes‐Rojas, C., Orkin, S. H., et al. (2015) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m114.044586 · Cited by 54
A key role for EZH2 in epigenetic silencing of HOX genes in mantle cell lymphoma
Kanduri, M., Sander, B., Ntoufa, S., Papakonstantinou, N., Sutton, L., Σταματόπουλος, Κ., Kanduri, C., & Rosenquist, R. (2013) · Epigenetics · doi:10.4161/epi.26546 · Cited by 54
Epigenetics in embryonic stem cells: regulation of pluripotency and differentiation
Atkinson, S. P., & Armstrong, L. (2007) · Cell and Tissue Research · doi:10.1007/s00441-007-0536-x · Cited by 54
Genomics and epigenomics of colorectal cancer
Schweiger, M. R., Hussong, M., Röhr, C., & Lehrach, H. (2013) · WIREs Systems Biology and Medicine · doi:10.1002/wsbm.1206 · Cited by 54
Unmasking the Lung Cancer Epigenome
Belinsky, S. A. (2015) · Annual Review of Physiology · doi:10.1146/annurev-physiol-021014-072018 · Cited by 54
Epigenetics: are there implications for personalised nutrition?
Burdge, G. C., Hoile, S. P., & Lillycrop, K. A. (2012) · Current Opinion in Clinical Nutrition & Metabolic Care · doi:10.1097/mco.0b013e3283567dd2 · Cited by 54
Xiang, S., Zou, P., Tang, Q., Zheng, F., Wu, J., Chen, Z., & Hann, S. S. (2017) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2017.12.001 · Cited by 54
Epigenetic Regulation: A Link between Inflammation and Carcinogenesis
Vezzani, B., Carinci, M., Previati, M., Giacovazzi, S., Sala, M. D., Gafà, R., Lanza, G., Wieckowski, M. R., Pinton, P., & Giorgi, C. (2022) · Cancers · doi:10.3390/cancers14051221 · Cited by 55
Jacob, E., Hod-Dvorai, R., Schif‐Zuck, S., & Avni, O. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m709886200 · Cited by 54
Targa, F. R., Rosa-Velázquez, I. A. D. L., Soto‐Reyes, E., & Benítez-Bribiesca, L. (2006) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2006.tb00420.x · Cited by 54
Histone modifications as a pathogenic mechanism of colorectal tumorigenesis
Gargalionis, A. N., Piperi, C., Adamopoulos, C., & Papavassiliou, A. G. (2012) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2012.05.002 · Cited by 53
DNA-Methylation Patterns in Trisomy 21 Using Cells from Monozygotic Twins
Sailani, M. R., Santoni, F. A., Letourneau, A., Borel, C., Makrythanasis, P., Hibaoui, Y., Popadin, K., Bonilla, X., Guipponi, M., Gehrig, C., et al. (2015) · PLOS ONE · doi:10.1371/journal.pone.0135555 · Cited by 49
Tao, Y., Liu, S., Briones, V. R., Geiman, T. M., & Muegge, K. (2011) · Nucleic Acids Research · doi:10.1093/nar/gkr611 · Cited by 53
Epigenetic Modifications in Prostate Cancer
Ngollo, M., Dagdemir, A., Karslı-Çeppioğlu, S., Judes, G., Pajon, A., Penault-Llorca, F. M., Boiteux, J., Bignon, Y., Guy, L., & Bernard-Gallon, D. J. (2014) · Epigenomics · doi:10.2217/epi.14.34 · Cited by 53
Liu, F., Gu, L., Cao, Y. J., Fan, X., Zhang, F., & Sang, M. (2015) · Biomarkers · doi:10.3109/1354750x.2015.1118537 · Cited by 53
ITIH5 mediates epigenetic reprogramming of breast cancer cells
Rose, M., Kloten, V., Noetzel, E., Gola, L., Ehling, J., Heide, T., Meurer, S. K., Gaiko-Shcherbak, A., Sechi, A. S., Huth, S., et al. (2017) · Molecular Cancer · doi:10.1186/s12943-017-0610-2 · Cited by 53
Coordinate H3K9 and DNA methylation silencing of ZNFs in toxicant-induced malignant transformation
Severson, P. L., Tokar, E. J., Vrba, L., Waalkes, M. P., & Futscher, B. W. (2013) · Epigenetics · doi:10.4161/epi.25926 · Cited by 52
Enhancer of zeste homolog 2 activates wnt signaling through downregulating CXXC finger protein 4
Lu, H., Sun, J., Wang, F., Feng, L., Ma, Y., Shen, Q., Jiang, Z., Sun, X., Wang, X., & Jin, H. (2013) · Cell Death and Disease · doi:10.1038/cddis.2013.293 · Cited by 53
Gong, C., Fujino, K., Monteiro, L. J., Gomes, A., Drost, R., Davidson‐Smith, H., Takeda, S., Khoo, U., Jonkers, J., Sproul, D., et al. (2014) · Oncogene · doi:10.1038/onc.2014.421 · Cited by 53
Epigenetic regulation of HIV-1 latency: focus on polycomb group (PcG) proteins
Khan, S., Iqbal, M., Tariq, M., Baig, S. M., & Abbas, W. (2018) · Clinical Epigenetics · doi:10.1186/s13148-018-0441-z · Cited by 53
Biology of Polycomb and Trithorax Group Proteins
Breiling, A., Sessa, L., & Orlando, V. (2007) · International review of cytology · doi:10.1016/s0074-7696(07)58002-2 · Cited by 54
Teitell, M. A., & Mikkola, H. K. A. (2006) · Pediatric Research · doi:10.1203/01.pdr.0000205155.26315.c7 · Cited by 52
Koturbash, I., Scherhag, A., Sorrentino, J. A., Sexton, K. G., Bodnar, W. M., Tryndyak, V., Latendresse, J. R., Swenberg, J. A., Beland, F. A., Pogribny, I. P., et al. (2010) · Environmental Health Perspectives · doi:10.1289/ehp.1002910 · Cited by 52
Epigenetic Therapeutics in Autoimmune Disease
Szyf, M. (2009) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-009-8172-8 · Cited by 52
DNA Methylation in Cancer: Epigenetic View of Dietary and Lifestyle Factors
Maleknia, M., Ahmadirad, N., Golab, F., Katebi, Y., & Ketabforoush, A. H. M. E. (2023) · Epigenetics Insights · doi:10.1177/25168657231199893 · Cited by 51
Li, X., Liu, J., Zhou, R., Huang, S., Huang, S., & Chen, X. (2009) · British Journal of Haematology · doi:10.1111/j.1365-2141.2009.07920.x · Cited by 51
Repeat-mediated genetic and epigenetic changes at the FMR1 locus in the Fragile X-related disorders
Usdin, K., Hayward, B. E., Kumari, D., Lokanga, R. A., Sciascia, N., & Zhao, X.-N. (2014) · Frontiers in Genetics · doi:10.3389/fgene.2014.00226 · Cited by 51
Road to early detection of pancreatic cancer: Attempts to utilize epigenetic biomarkers
Fukushige, S., & Horii, A. (2012) · Cancer Letters · doi:10.1016/j.canlet.2012.03.022 · Cited by 51
Kubiura‐Ichimaru, M., Okano, M., Kimurâ, H., Kawamura, F., & Tada, M. (2012) · Chromosome Research · doi:10.1007/s10577-012-9317-9 · Cited by 51
Sakamoto, Y., Watanabe, S., Ichimura, T., Kawasuji, M., Koseki, H., Baba, H., & Nakao, M. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m700011200 · Cited by 51
Chang, L., Lin, H., Tsai, M., Chou, R., Lee, F., Teng, C., Hsieh, M., Hung, H., Huang, L., Yu, Y., et al. (2014) · British Journal of Pharmacology · doi:10.1111/bph.12708 · Cited by 50
Epigenetic contributions to cancer metastasis
Rodenhiser, D. I. (2008) · Clinical & Experimental Metastasis · doi:10.1007/s10585-008-9166-2 · Cited by 50
Lyon, D., Elmore, L. W., Aboalela, N., Merrill, J. C., McCain, N. L., Starkweather, A. R., Elswick, R. K., & Jackson‐Cook, C. K. (2013) · Biological Research For Nursing · doi:10.1177/1099800413483545 · Cited by 50
Arosh, J. A., Lee, J., Starzinski‐Powitz, A., & Banu, S. K. (2015) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2015.03.023 · Cited by 50
Truax, A. D., Thakkar, M., & Greer, S. F. (2012) · PLoS ONE · doi:10.1371/journal.pone.0036013 · Cited by 50
Contribution of epigenetics in diabetic retinopathy
Kowluru, R. A., & Mishra, M. (2015) · Science China Life Sciences · doi:10.1007/s11427-015-4853-0 · Cited by 50
DNA Methylation Machinery in the Endometrium and Endometrial Cancer
CAPLAKOVA, V., Babušíková, E., Blahovcova, E., Balhárek, T., Zelieskova, M., & Hatok, J. (2016) · Anticancer Research · doi:10.21873/anticanres.10984 · Cited by 51
Pensold, D., Symmank, J., Hahn, A., Lingner, T., Salinas, G., Downie, B., Ludewig, F., Rotzsch, A., Haag, N., Andreas, N., et al. (2016) · Cerebral Cortex · doi:10.1093/cercor/bhw341 · Cited by 50
MUC1-C activates EZH2 expression and function in human cancer cells
Rajabi, H. N., Hiraki, M., Tagde, A., Alam, M., Bouillez, A., Christensen, C. L., Samur, M., Wong, K., & Kufe, D. W. (2017) · Scientific Reports · doi:10.1038/s41598-017-07850-0 · Cited by 50
Herviou, L., Kassambara, A., Boireau, S., Robert, N., Requirand, G., Müller‐Tidow, C., Vincent, L., Seckinger, A., Goldschmidt, H., Cartron, G., et al. (2018) · Clinical Epigenetics · doi:10.1186/s13148-018-0554-4 · Cited by 50
Chou, J.-L., Chen, L.-Y., Lai, H., & Chan, M. W. (2010) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2010.525353 · Cited by 51
Arabidopsis histone deacetylase 6: a green link to RNA silencing
Aufsatz, W., Stoiber, T., Rakic, B., & Naumann, K. (2007) · Oncogene · doi:10.1038/sj.onc.1210615 · Cited by 50
Lim, H. G., Suzuki, K., Cooper, D. A., & Kelleher, A. D. (2008) · Molecular Therapy · doi:10.1038/sj.mt.6300380 · Cited by 44
Epigenomic profiling of cancer cells
Gargiulo, G., & Minucci, S. (2008) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2008.07.021 · Cited by 50
Boscolo‐Rizzo, P., Furlan, C., Lupato, V., Polesel, J., & Fratta, E. (2017) · Clinical Epigenetics · doi:10.1186/s13148-017-0424-5 · Cited by 50
Epigenetic enzyme mutations as mediators of anti-cancer drug resistance
Chen, S., Zhao, Y., Liu, S., Zhang, J., Assaraf, Y. G., Cui, W., & Wang, L. (2022) · Drug Resistance Updates · doi:10.1016/j.drup.2022.100821 · Cited by 49
Xu, B., Zeng, D., Wu, Y., Zheng, R. Q., Gu, L., Lin, X., Hua, X., & Jin, G. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.197830 · Cited by 49
Lsh Mediated RNA Polymerase II Stalling at HoxC6 and HoxC8 Involves DNA Methylation
Tao, Y., Xi, S., Briones, V. R., & Muegge, K. (2010) · PLoS ONE · doi:10.1371/journal.pone.0009163 · Cited by 49
Epigenetic control on cell fate choice in neural stem cells
Hu, X.-L., Wang, Y., & Shen, Q. (2012) · Protein & Cell · doi:10.1007/s13238-012-2916-6 · Cited by 42
Ye, Y., McDevitt, M. A., Guo, M., Zhang, W., Galm, O., Gore, S. D., Karp, J. E., Maciejewski, J. P., Kowalski, J., Tsai, H., et al. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-1153 · Cited by 49
Li, L., Wu, J., Zheng, F., Tang, Q., Wu, W., & Hann, S. S. (2016) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-016-0388-x · Cited by 49
Epigenetic regulation of B cell fate and function during an immune response
Zhang, Y., & Good‐Jacobson, K. L. (2019) · Immunological Reviews · doi:10.1111/imr.12733 · Cited by 49
Portillo, F., Vázquez, J., & Pajares, M. A. (2020) · Biochimie · doi:10.1016/j.biochi.2020.02.015 · Cited by 49
Pensold, D., Reichard, J., van Loo, K. M. J., Ciganok-Hückels, N., Hahn, A., Bayer, C., Liebmann, L., Groß, J., Tittelmeier, J., Lingner, T., et al. (2020) · Cerebral Cortex · doi:10.1093/cercor/bhaa009 · Cited by 49
Broche, J., Kungulovski, G., Bashtrykov, P., Rathert, P., & Jeltsch, A. (2020) · Nucleic Acids Research · doi:10.1093/nar/gkaa1169 · Cited by 49
Badodi, S., Pomella, N., Zhang, X., Rosser, G., Whittingham, J., Niklison-Chirou, M. V., Lim, Y. M., Brandner, S., Morrison, G. M., Pollard, S. M., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-22379-7 · Cited by 49
Zhou, W., Feng, Y., Lin, C., Chi Kuan, C. H. A. O., He, Z., Zhao, S., Xue, J., Zhao, X., & Cao, W. (2023) · Advanced Science · doi:10.1002/advs.202207549 · Cited by 48
The Role of Genetics and Epigenetic Regulation in the Pathogenesis of Osteoarthritis
Kiełbowski, K., Herian, M., Bakinowska, E., Banach, B., Sroczyński, T., & Pawlik, A. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241411655 · Cited by 49
Chomiak, A. A., Tiedemann, R. L., Liu, Y., Kong, X., Cui, Y., Wiseman, A. K., Thurlow, K. E., Cornett, E. M., Topper, M. J., Baylin, S. B., et al. (2024) · Science Advances · doi:10.1126/sciadv.adk4423 · Cited by 48
Curik, N., Burda, P., Vargová, K., Pospíšil, V., Beličková, M., Vlckova, P., Savvulidi, F. G., Nečas, E., Hajkova, H., Haškovec, C., et al. (2012) · Leukemia · doi:10.1038/leu.2012.47 · Cited by 48
Specific inhibition of one DNMT1-including complex influences tumor initiation and progression
Cheray, M., Pacaud, R., Nadaradjane, A., Vallette, F. M., & Cartron, P. (2013) · Clinical Epigenetics · doi:10.1186/1868-7083-5-9 · Cited by 48
Epigenetic alterations associated with cholangiocarcinoma (Review)
Isomoto (2009) · Oncology Reports · doi:10.3892/or_00000428 · Cited by 48
Diagnostic role of Wnt pathway gene promoter methylation in non small cell lung cancer
Liu, S., Chen, X., Chen, R., Wang, J., Zhu, G., Jiang, J., Wang, H., Duan, S., & Huang, J. (2017) · Oncotarget · doi:10.18632/oncotarget.16754 · Cited by 48
Inhibition of HDAC1/2 Along with TRAP1 Causes Synthetic Lethality in Glioblastoma Model Systems
Nguyen, T. T. T., Zhang, Y., Shang, E., Shu, C., Quinzii, C. M., Westhoff, M., Karpel‐Massler, G., & Siegelin, M. D. (2020) · Cells · doi:10.3390/cells9071661 · Cited by 48
Epigenetic regulation of dental pulp stem cells and its potential in regenerative endodontics
Liu, Y., Gan, L., Cui, D., Yu, S.-H., Pan, Y., Zheng, L., & Wan, M. (2021) · World Journal of Stem Cells · doi:10.4252/wjsc.v13.i11.1647 · Cited by 48
DNA Methylation Changes and Inflammaging in Aging-Associated Diseases
Alimohammadi, M., Makaremi, S., Rahimi, A. A. R., Asghariazar, V., Taghadosi, M., & Safarzadeh, E. (2022) · Epigenomics · doi:10.2217/epi-2022-0143 · Cited by 47
Grimm, C., Chávez, L., Vilardell, M., Farrall, A. L., Tierling, S., Böhm, J. W., Grote, P., Lienhard, M., Dietrich, J., Timmermann, B., et al. (2013) · PLoS Genetics · doi:10.1371/journal.pgen.1003250 · Cited by 47
Genes and Conditions Controlling Mammalian Pre- and Post-implantation Embryo Development
Anifandis, G., Messini, C. I., Dafopoulos, K., & Messinis, I. E. (2014) · Current Genomics · doi:10.2174/1389202916666141224205025 · Cited by 47
Current Limitations And Future Opportunities For Epigenetic Therapies
Cherblanc, F., Chapman‐Rothe, N., Brown, R., & Fuchter, M. J. (2012) · Future Medicinal Chemistry · doi:10.4155/fmc.12.7 · Cited by 47
ChromNet: Learning the human chromatin network from all ENCODE ChIP-seq data
Lundberg, S. M., Tu, W. B., Raught, B., Penn, L. Z., Hoffman, M. M., & Lee, S.-I. (2016) · Genome Biology · doi:10.1186/s13059-016-0925-0 · Cited by 36
DZNep inhibits H3K27me3 deposition and delays retinal degeneration in the rd1 mice
Zheng, S., Xiao, L., Liu, Y., Wang, Y., Cheng, L. Z., Zhang, J., Yan, N., & Chen, D. (2018) · Cell Death and Disease · doi:10.1038/s41419-018-0349-8 · Cited by 47
Molecular alterations in meningiomas: Literature review
Pereira, B. J. A., Oba‐Shinjo, S. M., de Almeida, A. N., & Marie, S. K. N. (2018) · Clinical Neurology and Neurosurgery · doi:10.1016/j.clineuro.2018.12.004 · Cited by 47
Epigenetics of Bladder Cancer: Where Biomarkers and Therapeutic Targets Meet
Martínez, V. G., Munera-Maravilla, E., Bernardini, A., Rubio, C., Suárez-Cabrera, C., Segovia, C., Lodewijk, I., Dueñas, M., Martínez‐Fernández, M., & Paramio, J. M. (2019) · Frontiers in Genetics · doi:10.3389/fgene.2019.01125 · Cited by 48
Metadata
- Authors
- Viré, E., Brenner, C., Deplus, R., Blanchon, L., Fraga, M., Didelot, C., Morey, L., Van Eynde, A., Bernard, D., Vanderwinden, J.-M., Bollen, M., Esteller, M., Di Croce, L., de Launoit, Y., & Fuks, F.
- Affiliations
- Université Libre de Bruxelles (BE)
- Spanish National Cancer Research Centre (ES)
- KU Leuven (BE)
- Corresponding author
- Fuks, François
- ORCID
- Venue
- Nature
- Published
- 2005-12-14
- Volume
- 439
- Issue
- 7078
- Pages
- 871-874
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2053421436
- Cited by
- 2,204
- References
- 27
- Citations by year
- 2026: 32 · 2025: 52 · 2024: 60 · 2023: 72 · 2022: 89 · 2021: 110 · 2020: 95 · 2019: 94 · 2018: 95 · 2017: 119 · 2016: 151 · 2015: 134 · 2014: 128 · 2013: 135 · 2012: 164
- FWCI
- 33.51
- Type
- journal article
- Language
- en
- Update notices
- erratum (2007-04-12)
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Dépôt institutionnel de l'Université libre de Bruxelles (Université Libre de Bruxelles) (submittedVersion)
- HAL (submittedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- UCL Discovery (University College London) (submittedVersion)
- Funders
- Fédération Wallonie-Bruxelles
- Fondation pour la Recherche Médicale
- Ministerio de Economía y Competitividad
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Epigenetics and DNA Methylation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Chromatin Dynamics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Syndromes and Imprinting
- Keywords
- EZH2, Polycomb group proteins, DNA methylation, DNA methyltransferases, polycomb repressive complex 2, epigenetic silencing, chromatin repression, promoter methylation, protein-protein interaction
- MeSH terms
- Enhancer of Zeste Homolog 2 Protein, DNA (Cytosine-5-)-Methyltransferases, DNA-Binding Proteins, HeLa Cells, Humans, Promoter Regions, Genetic, Protein Binding, Repressor Proteins, Substrate Specificity, Transcription Factors, CpG Islands, DNA Methylation, Gene Silencing, Epigenesis, Genetic, Chromatin Immunoprecipitation, Polycomb-Group Proteins, Polycomb Repressive Complex 2
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.